Prostate cancer and PSA testing. How much do men think they know? What do they know?O'Connell, D LCarmichael, L KSmith, D PGattellari, MChambers, S KC, P PinnockSlevin, TWard, J E
收稿方向:以下是PROSTATE CANCER AND PROSTATIC DISEASES所涵盖的一般主题的非详尽清单: 替代疗法;血管生成;针对生长因子的反义寡核苷酸;近距离治疗;成形放射治疗;适形放疗;回旋加速器快中子治疗;加强根治性前列腺切除术的效果;前列腺癌和前列腺疾病的流行病学;家族性前列腺癌;游离于总的PSA;前列腺癌的基因治疗;前列腺...
The main screening tool for prostate cancer is the PSA test, which measures levels of a protein calledprostate-specific antigen(PSA) in the blood. In the past, some experts have suggested that PSA testing caused more harm than good, saying it can lead to unnecessary biopsies and therapies for...
PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer. Prostate Cancer Prostatic Dis. 2022; https://doi.org/10.1038/s41391-022-00549-y Visser WCH, de Jong H, Steyaert S, Melchers WJG, Mulders PFA, Schalken ...
PSA and Prostate Cancer 作者: Saylor, Jake A.; Michaels, Lionel B.; 页数: 241定价: 1120.00元ISBN: 9781608768950豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 推荐 我来说两句 短评 ··· 热门 还没人写过短评呢 我要写书评 PSA and Prostate Cancer的书评 ··· ( 全部0 ...
prostate cancer often doesn't grow very fast. Prostate cancer is graded by a Gleason score, which measures how abnormal or different from normal cells are. There are also other tests to see if the cancer has spread: bone scan, CT scan, MRI, and even...
In subject area: Medicine and Dentistry Metastatic castrate-resistant prostate cancer (CRPC) is a disease state characterized by a testosterone level of less than 50 ng/dL, with 2 consecutive increases in prostate-specific antigen (PSA) with a PSA level of 2 ng/dL or more. ...
PSA is useful for detecting a relapse of prostate cancer after surgery or radiation. After prostate cancer surgery, PSA is normally undetectable, and even small rises could point to a recurrence. After curative radiation, the PSA generally stays under 1.0 long-term. However, there are exceptions...
Despite survival improvements achieved over the last two decades, prostate cancer remains lethal at the metastatic castration-resistant stage (mCRPC) and new therapeutic approaches are needed. Germinal and/or somatic alterations of DNA-damage response pa
The incidence of prostate cancer (PCa) in India is shown to have increased with increasing life-expectancy, use of diagnostic marker like prostate specific antigen (PSA) and changing life style. Prostate cancer occurs at an old age with peak incidence occurring after 65 years of age. Since PCa...